/S2M.ST
S2M.ST Stock - S2Medical AB (publ)
Healthcare|Medical - Instruments & SuppliesSTO
$0.01-0.95%
$0.00 (-0.95%) • Dec 23
39
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.13
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.4
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for S2M.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.89
52W High$0.03
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $14.91M | $6.97M | $4.67M | $7.70M | $25.62M |
| Gross Profit | $14.14M | $5.04M | $5.17M | $7.10M | $10.05M |
| Gross Margin | 94.9% | 72.3% | 110.6% | 92.2% | 39.2% |
| Operating Income | $5.79M | $-15,264,000 | $-27,688,598 | $-19,835,843 | $-15,061,789 |
| Net Income | $5.77M | $-22,707,457 | $-29,456,402 | $-20,079,249 | $-15,082,085 |
| Net Margin | 38.7% | -325.7% | -630.7% | -260.8% | -58.9% |
| EPS | $0.01 | $-0.14 | $-0.45 | $-0.35 | $-0.33 |
Company Overview
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in Linköping, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
S2M.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2024
EPS Surprise History
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q2 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 21, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 30, 2024 | — | $0.02 | — | — |
Q2 2024 | Jun 7, 2024 | — | $0.00 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 29, 2023 | — | $-0.04 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.26 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.05 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.09 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.32 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.36 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.40 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.16 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.11 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.10 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.08 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.48 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.10 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.09 | — | — |
Latest News
Loading news...
Frequently Asked Questions about S2M.ST
What is S2M.ST's current stock price?
S2Medical AB (publ) (S2M.ST) is currently trading at $0.01 per share. The stock has moved -0.95% today.
What is the analyst price target for S2M.ST?
No analyst price targets are currently available for this stock.
What sector is S2Medical AB (publ) in?
S2Medical AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.
What is S2M.ST's market cap?
S2Medical AB (publ) has a market capitalization of $0.01 billion, making it a small-cap company.
Does S2M.ST pay dividends?
No, S2Medical AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCMH.ST
Chordate Medical Holding AB (publ)
$0.61
Mkt Cap: $0.0B
FLUI.ST
Fluicell AB (publ)
$11.30
Mkt Cap: $0.0B
GABA.ST
Gabather AB (publ)
$0.03
Mkt Cap: $0.0B
LIDDS.ST
LIDDS AB (publ)
$0.04
Mkt Cap: $0.0B
ODI.ST
ODI Pharma AB
$3.22
Mkt Cap: $0.1B
PLUN.ST
ProstaLund AB (publ)
$0.21
Mkt Cap: $0.0B
PROGEN.ST
Prostatype Genomics AB (publ)
$0.35
Mkt Cap: $0.0B
QUIA.ST
Quia Pharma AB (publ)
$0.00
Mkt Cap: $0.0B
SPERM.ST
Spermosens AB
$0.01
Mkt Cap: $0.0B
STABL.ST
Stayble Therapeutics AB (publ)
$0.21
Mkt Cap: $0.0B
Explore stocks similar to S2M.ST for comparison